WO2007019719A1 - Cooling compounds - Google Patents

Cooling compounds Download PDF

Info

Publication number
WO2007019719A1
WO2007019719A1 PCT/CH2006/000427 CH2006000427W WO2007019719A1 WO 2007019719 A1 WO2007019719 A1 WO 2007019719A1 CH 2006000427 W CH2006000427 W CH 2006000427W WO 2007019719 A1 WO2007019719 A1 WO 2007019719A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
isopropyl
compounds
carbons
branched alkyl
Prior art date
Application number
PCT/CH2006/000427
Other languages
French (fr)
Inventor
Karen Ann Bell
Christophe Galopin
Jay Patrick Slack
Lori Tigani
Original Assignee
Givaudan Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Givaudan Sa filed Critical Givaudan Sa
Priority to CN200680029790XA priority Critical patent/CN101257949B/en
Priority to EP06761278.8A priority patent/EP1917074B1/en
Priority to BRPI0616821-3A priority patent/BRPI0616821B1/en
Priority to US11/990,103 priority patent/US9452982B2/en
Priority to ES06761278.8T priority patent/ES2668361T3/en
Priority to JP2008526348A priority patent/JP5383191B2/en
Publication of WO2007019719A1 publication Critical patent/WO2007019719A1/en
Priority to US15/276,248 priority patent/US10221136B2/en
Priority to US16/290,300 priority patent/US11059783B2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40Acylated substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • A23L2/56Flavouring or bittering agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/24Thermal properties
    • A61K2800/244Endothermic; Cooling; Cooling sensation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92Oral administration

Definitions

  • This invention relates to cooling compounds.
  • Cooling compounds that is, chemical compounds that impart a cooling sensation to the skin or the mucous membranes of the body, are well known to the art and are widely used in a variety of products such as foodstuffs, tobacco products, beverages, dentifrices, mouthwashes and toiletries.
  • X, Y and Z are selected independently from the group consisting of H, halogen, OH, Me, Et, MeO and EtO, and R 1 , R 2 and R 3 together comprise at least 6 carbons, selected such that
  • R 1 is selected from the group consisting of H, Me, Et, isopropyl and
  • R and R are independently selected from the group consisting of Me. Et, isopropyl and C 4 -branched alkyl; or
  • BESTATIGUNGSKOPIE any two or all of R 1 , R 2 and R 3 together form a monocyclic, bicyclic or tricyclic radical having up to 10 carbons.
  • Me is defined as methyl
  • Et is defined as ethyl
  • Examples of cyclic radicals as described under (b) above include 3-para-menthyl, bornyl and adamantyl.
  • the compounds of formula (I) may comprise one or more chiral centres and as such may exist as a mixture of stereoisomers, or they may be resolved as isomerically pure forms. Resolving stereoisomers adds to the complexity of manufacture and purification of these compounds and so it is preferred to use the compounds as mixtures of their stereoisomers simply for economic reasons. However, if it is desired to prepare individual stereoisomers, this may be achieved according to methods known in the art, e.g. preparative HPLC and GC or by stereoselective syntheses.
  • the compounds are those in which X, Y, Z are H, OH, Me or OMe. In certain embodiments, the compounds are those in which m is 2; X, Y and Z are H or Me and R 1 , R 2 and R 3 are taken from Table 1.
  • Table 1 Exemplary R , R and R groups.
  • a particularly effective compound is that in which R 1 is H and R 2 and R 3 together form a 3-p-menthyl ring.
  • Examples of effective compounds are (lR,2S,5R)-2-isopropyl-5-methyl-N- (pyridinalkyl)cyclohexanecarboxamide and (2S,5R)-2-isopropyl-5-methyl-N- (pyridinalkyl)cyclohexanecarboxamide.
  • a compound is also provided according to formula I as hereinabove described, in which X, Y, Z, R 1 are H and R 2 , R 3 have the meanings given hereinabove.
  • R 1 is hydrogen and R 2 and R 3 are independently selected from the group consisting of Me, Et and C 3 -C 4 branched alkyl; or R 1 , R 2 and R 3 together form a monocyclic, bicyclic or tricyclic radical having up to 10 carbons.
  • the compounds may be easily prepared and isolated by art-recognized methods
  • the compounds may be used in products that are applied to the mouth or the skin to give a cooling sensation.
  • applying is meant any form of bringing into contact, for example, oral ingestion or, in the case of tobacco products, inhalation, hi the case of application to the skin, it may be, for example, by including the compound in a cream or salve, or in a sprayable composition.
  • the range of products in which the compounds may be used is very wide, and it includes by way of example only, dentifrices such as toothpaste and toothgel, mouthwashes, foodstuffs, beverages, confectionery, tobacco products, skin creams and ointments, both cosmetic and medicinal.
  • the compounds may be used alone or in combination with other cooling compounds known in the art, e.g., menthol, menthone, isopulegol, N-ethyl p- menthanecarboxamide (WS-3), N,2,3-trimethyl-2-isopropylbutanamide (WS-23), menthyl lactate (FrescolatTM ML), menthone glycerine acetal (FrescolatTM MGA), mono-menthyl succinate (PhyscoolTM), mono-menthyl glutarate, O-menthyl glycerine (Cool ActTM 10), menthyl-N,N-dimethylsuccinamate and 2-sec-butylcyclohexanone (FreskomentheTM).
  • other cooling compounds known in the art, e.g., menthol, menthone, isopulegol, N-ethyl p- menthanecarboxamide (WS-3), N,2,3-tri
  • Peppermint oil Terpeneless 0.300 g
  • PluronicTM F127 nonionic surfactant 5.000 g Sodium Saccharin 0.600 g
  • the chemicals are mixed in the toothgel, a piece of toothgel is put on a toothbrush and a panelist's teeth are brushed.
  • the mouth is rinsed with water and the water is spit out. An intense cooling sensation is felt by the panelist in all areas of the mouth.

Abstract

A method of providing a cooling effect to a product includes the incorporation into the product of at least one compound of the formula (I) in which m is a number between 0 and 2, X, Y and Z are selected independently from the group consisting of H, halogen, OH, Me, Et, MeO and EtO, and R1, R2 and R3 together comprise at least 6 carbons, selected such that (a) (i) R1 is selected from the group consisting of H, Me, Et, isopropyl and C4-C5 branched alkyl; and (ii) R2 and R3 are independently selected from the group consisting of Me, Et, isopropyl and C4-branched alkyl; or (b) any two or all of R1, R2 and R3 together form a monocyclic, bicyclic or tricyclic radical having up to 10 carbons. The compounds confer substantial cooling effects on compositions applied to the skin or taken orally, such as toothpastes, mouthwashes, foodstuffs, beverages, confectionery, tobacco products, skin creams and ointments.

Description

COOLING COMPOUNDS
This invention relates to cooling compounds.
Cooling compounds, that is, chemical compounds that impart a cooling sensation to the skin or the mucous membranes of the body, are well known to the art and are widely used in a variety of products such as foodstuffs, tobacco products, beverages, dentifrices, mouthwashes and toiletries.
One class of cooling compounds that have enjoyed substantial success consists of N- substituted p-menthane carboxamides. Examples of these compounds are described in, for example, British Patents GB 1,351,761-2 and United States Patent US 4,150,052.
It has now been found that a particular selection of such compounds exhibits a cooling effect that is both surprisingly strong and long-lasting. A method is provided, therefore, of providing a cooling effect to a product, comprising the incorporation into the product of at least one compound of the formula I
Figure imgf000002_0001
in which m is a number between 0 and 2, X, Y and Z are selected independently from the group consisting of H, halogen, OH, Me, Et, MeO and EtO, and R1, R2 and R3 together comprise at least 6 carbons, selected such that
(a) (i) R1 is selected from the group consisting of H, Me, Et, isopropyl and
C4-C5 branched alkyl; and
(ii) R and R are independently selected from the group consisting of Me. Et, isopropyl and C4-branched alkyl; or
BESTATIGUNGSKOPIE (b) any two or all of R1, R2 and R3 together form a monocyclic, bicyclic or tricyclic radical having up to 10 carbons.
Me is defined as methyl, and Et is defined as ethyl.
Examples of cyclic radicals as described under (b) above include 3-para-menthyl, bornyl and adamantyl.
The compounds of formula (I) may comprise one or more chiral centres and as such may exist as a mixture of stereoisomers, or they may be resolved as isomerically pure forms. Resolving stereoisomers adds to the complexity of manufacture and purification of these compounds and so it is preferred to use the compounds as mixtures of their stereoisomers simply for economic reasons. However, if it is desired to prepare individual stereoisomers, this may be achieved according to methods known in the art, e.g. preparative HPLC and GC or by stereoselective syntheses.
In some embodiments, the compounds are those in which X, Y, Z are H, OH, Me or OMe. In certain embodiments, the compounds are those in which m is 2; X, Y and Z are H or Me and R1, R2 and R3 are taken from Table 1.
Table 1: Exemplary R , R and R groups.
Figure imgf000003_0001
A particularly effective compound is that in which R1 is H and R2 and R3 together form a 3-p-menthyl ring. Examples of effective compounds are (lR,2S,5R)-2-isopropyl-5-methyl-N- (pyridinalkyl)cyclohexanecarboxamide and (2S,5R)-2-isopropyl-5-methyl-N- (pyridinalkyl)cyclohexanecarboxamide. Particular examples of these are (1R,2S,5R)- 2-isopropyl-5-methyl-N-(2-(pyridin-4-yl)etliyl)cyclohexanecarboxamide and (2S,5R)- 2-isopropyl-5-methyl-N-(2-(pyridin-4-yl)ethyl)cyclohexanecarboxamide
Certain of the compounds are novel. A compound is therefore provided of the formula I as hereinabove described, in which m=2 and X, Y, Z, R1, R2, R3 have the meanings given hereinabove, with the proviso that when R2 and R3 form a para- menthyl ring, at least one of R1, X, Y and Z is a moiety other than H.
A compound is also provided according to formula I as hereinabove described, in which X, Y, Z, R1 are H and R2, R3 have the meanings given hereinabove. In certain embodiments R1 is hydrogen and R2 and R3 are independently selected from the group consisting of Me, Et and C3-C4 branched alkyl; or R1, R2 and R3 together form a monocyclic, bicyclic or tricyclic radical having up to 10 carbons.
The compounds may be easily prepared and isolated by art-recognized methods
They are distinguished from similar compounds of the prior art by their surprisingly high cooling effect (up to 100 times higher than that of similar known compounds) and by the longevity of the cooling effect. These compounds also have a high solubility in oily solvents, such as mint oils, and acidic aqueous solutions, such as soft drinks. These features expand the uses of cooling compounds to a larger variety of products
The compounds may be used in products that are applied to the mouth or the skin to give a cooling sensation. By "applying" is meant any form of bringing into contact, for example, oral ingestion or, in the case of tobacco products, inhalation, hi the case of application to the skin, it may be, for example, by including the compound in a cream or salve, or in a sprayable composition. There is also provided, therefore, a method of providing a cooling effect to the mouth or skin by applying thereto a product comprising a compound as hereinabove described. The range of products in which the compounds may be used is very wide, and it includes by way of example only, dentifrices such as toothpaste and toothgel, mouthwashes, foodstuffs, beverages, confectionery, tobacco products, skin creams and ointments, both cosmetic and medicinal.
The compounds may be used alone or in combination with other cooling compounds known in the art, e.g., menthol, menthone, isopulegol, N-ethyl p- menthanecarboxamide (WS-3), N,2,3-trimethyl-2-isopropylbutanamide (WS-23), menthyl lactate (Frescolat™ ML), menthone glycerine acetal (Frescolat™ MGA), mono-menthyl succinate (Physcool™), mono-menthyl glutarate, O-menthyl glycerine (Cool Act™ 10), menthyl-N,N-dimethylsuccinamate and 2-sec-butylcyclohexanone (Freskomenthe™).
Certain embodiments are now further described by means of the following non- limiting examples.
Example 1
Preparation of N-(4-pyridinyl) p-menthanecarboxamide [(lR,2S,5R)-2- isopropyl-5-methyl-N-(2-(pyridin-4-yl)ethyl)cyclohexanecarboxamide1
To a flask are added 4.7 g (50 mmol) of pyridin-4-ylamine, 4.04 mL of pyridine and 100 mL MtBE. To this mixture, 10 g of p-menthanecarboxyl chloride are added dropwise over 5 minutes. The reaction mixture is stirred for 24 hours. To the reaction mixture, 5OmL of water are added. The mixture is separated. The organic layer is washed with 50 mL of water and 50 mL of brine. The organic layer is dried over MgSO4. The solvent is evaporated in vacuo to afford the crude product, which is recrystallized from hexanes to afford 6.2 g of the desired product with the following spectroscopic properties: MS: 260 ([M+']), 217, 149, 121, 95
1H NMR (300 MHz; CDCl3) δ: 8.49 (d, 2H), 7.77 (s, IH), 7.52 (d, 2H), 2.22 (td, IH), 1.9 (broad d, 2H), 1.85 -1.57 (m, 3H), 1.44 -1.22 (m, 2H), 1.16- 0.99 (m, 2H), 0.94 (d, 3H), 0.91 (d, 3H), 0.81 (d, 3H) 13 C NMR (75 MHz; CDCl3) δ: 175.4, 150.5, 145.0, 113.4, 50.7, 44.3, 39.25, 34.3, 32.1, 28.7, 23.7, 22.1, 21.2, 16.1
Example 2
Preparation of N-(2-pyridin-2-ylethyl) p-menthanecarboxamide [(lR,2S,5R)-2- isopropyl-5-methyl-N-(2-(pyridin-2-yl)ethyl)cyclohexanecarboxamide]:
A preparation similar to that described in example 1 gives the desired product with the following spectroscopic properties: MS: 288 ([M+']), 273, 245, 149, 121, 95
1H NMR (300 MHz; DMSO) δ: 8.53 (d, IH), 7.62 (td, IH), 7.16 (m, 2H), 6.43 (s, IH), 3.67 (nontuplet, 2H), 3.00 (t, 2H), 1.95 (td, IH), 1.84-1.53 (m, 4H), 1.47 (broad t, IH), 1.4-1.1 (m, 2H), 0.87 (d, 3H), 0.84 (d,3H), 0.66 (d, 3H)
13C NMR (75 MHz; DMSO) δ: 175.8, 159.7, 148.9, 136.7, 123.6, 121.55, 49.8, 44.3, 39.4, 38.35, 36.9, 34.6, 32.3, 28.55, 23.9, 22.3, 21.3, 15.95
Example 3
Preparation of 2-isopropyl-2,3-dimethyl-N-(2-(pyridin-2-yl)ethyl)butanamide:
A preparation similar to that described in example 1, using 2-isopropyl-2,3- dimethylbutanoyl chloride, gives the desired product with the following spectroscopic properties:
MS: 262 ([M+]), 220, 205, 149, 121, 106, 93
1H NMR (300 MHz; CDC13) 8.53 (d, IH), 7.63 (t, IH), 7.16 (m, 2H), 6.69 (s, IH),
3.67 (dd, 2H), 2.99 (t, 2H), 1.96 (m, 2H), 0.96 (s, 3H), 0.85 (d, 6H), 0.79 (d, 6H)
13C (75MHz; CDCL3) 175.6, 160.0, 149.1, 136.6, 123.4, 121.5, 51.4, 38.4, 36.9,
32.6, 18.1, 17.4, 14.1 Example 4
Assessment of cooling effect
A small group of panelists is asked to taste various aqueous solutions of cooling compounds and indicate which solutions had a cooling intensity similar or slightly higher than that of a solution of menthol at 2ppm. The same panel is asked to taste these solutions at the chosen concentrations and to record the cooling intensity at regular time intervals until no cooling could be sensed in the mouth. The results are shown in Table 2.
Table 2: Experiments on cooling intensity and longevity.
Figure imgf000007_0001
From Table 2, it can be seen that the compounds of Formula I are up to 100 times stronger and last longer than menthol, the reference cooling compound. Compounds of Formula I are also much stronger than WS-3, the best cooling compound of the prior art.
In a second experiment, the same panel is asked to taste various solutions of compounds having various concentrations and to indicate which of these solutions had a cooling intensity similar to or slightly higher than that of a solution of menthol at 2ppm. This is the "isointensive concentration". The results are shown in Table 3. 1 "X 1
Table 3 : Intensity of compounds where R +R = p-menthane and R =X= Y=Z=H
Figure imgf000008_0001
* compound of Example 1 ** compound of Example 2
From Table 2 and 3, it can be seen that compounds of Formula I with various chain lengths and substitution patterns all have lower usage levels than the reference cooling chemicals, menthol and WS-3.
Example 5
Application in mouthwash
Alcohol 95% 177mL
Sorbitol 70% 250 g
Compound of example 1 as a 1% solution in alcohol 5OmL
Peppermint oil, Terpeneless 0.300 g
Methyl salicylate 0.640 g
Eucalyptol 0.922 g
Thymol 0.639 g
Benzoic acid 1.500 g
Pluronic™ F127 nonionic surfactant 5.000 g Sodium Saccharin 0.600 g
Sodium Citrate 0.300 g
Citric Acid 0.100 g
Water q.s. 1 liter
All the ingredients are mixed. 30 mL of obtained solution is put in the mouth, swished around, gargled and spit out. An icy-cool sensation is felt in every area of the mouth as well as lips.
Example 6
Application in toothpaste
Opaque toothgel 97.000 g
Compound of example 2 as a 2% solution in propylene glycol 2.50Og
Peppermint oil, Terpeneless 0.500g
The chemicals are mixed in the toothgel, a piece of toothgel is put on a toothbrush and a panelist's teeth are brushed. The mouth is rinsed with water and the water is spit out. An intense cooling sensation is felt by the panelist in all areas of the mouth.
Example 7 Application in beverages
1.5 mg of the compound of example 2 is dissolved in a 355 mL (12 fl oz.) can of clear lemon/lime soda. A panelist experiences an agreeable delayed cooling sensation in the mouth with no throat burning. No unpleasant after-taste is observed.
Although the invention has been described in detail through the above detailed description and the preceding examples, these examples are for the purpose of illustration only and it is understood that variations and modifications can be made by one skilled in the art without departing from the spirit and the scope of the invention. It should be understood that the embodiments described above are not only in the alternative, but can be combined.

Claims

Claims:
1. A method of providing a cooling effect to a product, comprising the incorporation into the product of at least one compound of the formula I
Figure imgf000010_0001
in which m is a number between 0 and 2, X, Y and Z are selected independently from the group consisting of H, halogen, OH, Me, Et, MeO and EtO, and R1, R2 and R3 together comprise at least 6 carbons, selected such that
(a) (i) R1 is selected from the group consisting of H, Me, Et, isopropyl and C4-C5 branched alkyl; and
(ii) R2 and R3 are independently selected from the group consisting of Me, Et, isopropyl and C4-branched alkyl; or
(b) any two or all of R1, R2 and R3 together form a monocyclic, bicyclic or tricyclic radical having up to 10 carbons.
2. A method according to claim 1, in which those in which X, Y, Z are independently selected from H, OH, Me and OMe.
3. A method according to claim 1, in which m is 2; X, Y and Z are independently selected from H and Me and R1, R2 and R3 are selected according to the following table:
Figure imgf000011_0002
4. A method according to claim 1, in which R1 is H and R2 and R3 together form a 3-p-menthyl ring.
5. A product adapted to be applied to the skin or taken orally, comprising at least one compound according to the formula I
Figure imgf000011_0001
in which m is a number between 0 and 2, X, Y and Z are selected independently from the group consisting of H, halogen, OH, Me, Et, MeO and EtO, and R1, R2 and R3 together comprise at least 6 carbons, selected such that
(a) (i) R1 is selected from the group consisting of H, Me, Et, isopropyl and C4-C5 branched alkyl; and
(ii) R2 and R3 are independently selected from the group consisting of Me, Et, isopropyl and C4-branched alkyl; or
(b) any two or all of R1, R2 and R3 together form a monocyclic, bicyclic or tricyclic radical having up to 10 carbons.
6. A compound of Formula I
Figure imgf000012_0001
in which m=2 and X, Y and Z are selected independently from the group consisting of H, halogen, OH, Me, Et, MeO and EtO, and R1, R2 and R3 together comprise at least 6 carbons, selected such that
(a) (i) R1 is selected from the group consisting of H, Me, Et, isopropyl and C4-C5 branched alkyl; and
(ii) R2 and R3 are independently selected from the group consisting of Me, Et, isopropyl and C4-branched alkyl; or
(b) any two or all of R1, R2 and R3 together form a monocyclic, bicyclic or tricyclic radical having up to 10 carbons;
with the proviso that, when R and R form a para-menthyl ring, at least one of
R1, X, Y and Z is a moiety other than H.
PCT/CH2006/000427 2005-08-15 2006-08-14 Cooling compounds WO2007019719A1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
CN200680029790XA CN101257949B (en) 2005-08-15 2006-08-14 Cooling compounds
EP06761278.8A EP1917074B1 (en) 2005-08-15 2006-08-14 Cooling compounds
BRPI0616821-3A BRPI0616821B1 (en) 2005-08-15 2006-08-14 Method for providing a cooling effect in a product and product having a cooling effect
US11/990,103 US9452982B2 (en) 2005-08-15 2006-08-14 Pyridinyl cyclohexanecarboxamide cooling compounds
ES06761278.8T ES2668361T3 (en) 2005-08-15 2006-08-14 Refrigerant compounds
JP2008526348A JP5383191B2 (en) 2005-08-15 2006-08-14 Refreshing compound
US15/276,248 US10221136B2 (en) 2005-08-15 2016-09-26 Pyridinyl cyclohexanecarboxamide cooling compounds
US16/290,300 US11059783B2 (en) 2005-08-15 2019-03-01 Pyridinyl cyclohexanecarboxamide cooling compounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70815305P 2005-08-15 2005-08-15
US60/708,153 2005-08-15

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US11/990,103 A-371-Of-International US9452982B2 (en) 2005-08-15 2006-08-14 Pyridinyl cyclohexanecarboxamide cooling compounds
US15/276,248 Continuation US10221136B2 (en) 2005-08-15 2016-09-26 Pyridinyl cyclohexanecarboxamide cooling compounds

Publications (1)

Publication Number Publication Date
WO2007019719A1 true WO2007019719A1 (en) 2007-02-22

Family

ID=37215970

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CH2006/000427 WO2007019719A1 (en) 2005-08-15 2006-08-14 Cooling compounds

Country Status (7)

Country Link
US (3) US9452982B2 (en)
EP (1) EP1917074B1 (en)
JP (1) JP5383191B2 (en)
CN (1) CN101257949B (en)
BR (1) BRPI0616821B1 (en)
ES (1) ES2668361T3 (en)
WO (1) WO2007019719A1 (en)

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008107137A2 (en) * 2007-03-02 2008-09-12 Givaudan Nederland Services B.V. Compositions comprising a physiological coolant
WO2008141469A2 (en) * 2007-05-23 2008-11-27 Givaudan Sa Butone derivatives useful as cooling agents
WO2008148234A1 (en) 2007-06-06 2008-12-11 Givaudan Sa Salt enhancement
WO2008151460A2 (en) 2007-06-13 2008-12-18 Givaudan Sa Cooling compounds
WO2009012609A1 (en) 2007-07-23 2009-01-29 Givaudan Sa Amide addition reaction
WO2009115165A2 (en) * 2008-03-20 2009-09-24 Beiersdorf Ag Cooling preparations for contact with human skin and/or mucous membranes, containing (1r,2s,5r)-2-isopropyl-5-methyl-n-(2-(pyridin-2-yl)ethyl-cyclohexane carboxamide and/or (1r,2s,5r)-n-(4-(cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexane carboxamide
WO2009115164A2 (en) * 2008-03-20 2009-09-24 Beiersdorf Ag Cooling cosmetic or dermatological preparations having a content of (1r,2s,5r)-2-isopropyl-5-methyl-n-(2-(pyridyne-2-yl)ethyl-cyclohexane carboxamide and/or (1r,2s,5r)-n-(4-(cyanomethyl)phenyl)-2-isopropyl-5- methylcyclohexane carboxamide comprising menthoxypropane diol
WO2009115163A2 (en) * 2008-03-20 2009-09-24 Beiersdorf Ag Cooling cosmetic or dermatological preparations having a content of (1r,2s,5r)-2-isopropyl-5-methyl-n-(2-(pyridyne-2-yl)ethyl-cyclohexane carboxamide and/or (1r,2s,5r)-n-(4-(cyanomethyl)phenyl)-2-ispropyl-5-methylcyclohexane carboxamide for the reduction of erythema
WO2009127282A1 (en) * 2008-03-20 2009-10-22 Beiersdorf Ag Preparations for reducing itching and other paraesthesias which with (1r,2s,5r)-2-isopropyl-5-methyl-n-(2-(pyridin-2yl)ethylcyclohexyl carboxamide and/or (1r,2s,5r)-n84-(cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexyl carboxamide
WO2009140783A1 (en) * 2008-05-22 2009-11-26 Givaudan Sa Cooling composition
WO2010076123A2 (en) 2008-12-30 2010-07-08 Unilever Nv A non-freezing dentifrice composition
WO2010128026A2 (en) * 2009-05-05 2010-11-11 Givaudan Sa Organic compounds
WO2010149798A2 (en) 2010-06-14 2010-12-29 Symrise Ag Use of polyols for enhancing the cooling effect of a cooling substance and cooling mixtures having an enhanced cooling effect
WO2011012671A1 (en) 2009-07-29 2011-02-03 Givaudan Sa Improvements in or relating to organic compounds
WO2011012421A1 (en) 2009-07-29 2011-02-03 Unilever Nv A dentifrice composition comprising polyethyleneglycol and a cooling agent
WO2011061330A2 (en) 2009-11-20 2011-05-26 Symrise Ag Use of physiological cooling active ingredients, and agents containing such active ingredients
WO2012113873A2 (en) 2011-02-23 2012-08-30 Givaudan Sa Organic compounds
US8309598B2 (en) 2007-12-19 2012-11-13 Givaudan S.A. Cooling compounds
US8357318B2 (en) 2007-05-08 2013-01-22 Givaudan S.A. Wax encapsulation
WO2013014235A2 (en) 2011-07-26 2013-01-31 Givaudan Sa Rinse-off compositions
US8377422B2 (en) 2007-12-07 2013-02-19 Givaudan S.A. Carboxamide derivatives having cooling properties
WO2013041621A1 (en) 2011-09-20 2013-03-28 Basf Se Low molecular weight modulators of the cold-menthol receptor trpm8 and use thereof
USRE44339E1 (en) 2003-11-21 2013-07-02 Givaudan S.A. N-substituted P-menthane carboxamides
US8710096B2 (en) 2008-08-26 2014-04-29 Basf Se Detection and use of low molecular-weight modulators of the cold-menthol receptor TRPM8
US9029415B2 (en) 2010-06-14 2015-05-12 Symrise Ag Cooling mixtures with an enhanced cooling effect of 5-methyl-2-(propane-2-yl)cyclohexyl-N-ethyloxamate
WO2019043164A1 (en) 2017-08-31 2019-03-07 Basf Se Use of physiological cooling active ingredients, and compositions comprising such active ingredients
EP3689324A1 (en) 2019-02-04 2020-08-05 Symrise AG New cooling agents and preparations comprising them
WO2022105986A1 (en) 2020-11-17 2022-05-27 Symrise Ag Novel cooling agents and preparations containing same
WO2022207944A2 (en) 2022-07-11 2022-10-06 Symrise Ag Novel mixtures and uses of (2e)-3-(1,3-benzodioxol-5-yl)-n-phenyl-n-(tetrahydro-3-furanyl)-2-propenamide
WO2023144326A1 (en) 2022-01-28 2023-08-03 Symrise Ag New coolants, and preparations containing same

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2018004049A (en) 2015-10-01 2018-09-28 Senomyx Inc Compounds useful as modulators of trpm8.
AU2017322544B2 (en) 2016-09-12 2022-06-02 St Ip Holding Ag Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-1.2-dithiole-3-thione, taste-modified formulations, and methods of making and using same
JP2019531344A (en) 2016-09-12 2019-10-31 エスティー アイピー ホールディング エージー Formulas of 4-methyl-5- (pyrazin-2-yl) -3H-1,2-dithiol-3-thione and methods for their production and use
JP2018203645A (en) * 2017-05-31 2018-12-27 ライオン株式会社 Composition for oral cavity
BR112021001176A2 (en) 2018-08-10 2021-04-27 Firmenich Incorporated 2tr54 antagonists and compositions and uses thereof
JP2020070263A (en) * 2018-11-01 2020-05-07 ライオン株式会社 Liquid composition for oral cavity
US11135220B1 (en) 2020-04-08 2021-10-05 St Ip Holding Ag Methods of treating viral infections with formulated compositions comprising 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH491111A (en) * 1966-01-28 1970-05-31 Geigy Ag J R Process for the preparation of new amides of aliphatic carboxylic acids
DE2458562A1 (en) * 1973-12-12 1975-06-19 Wilkinson Sword Ltd CONSUMER PRODUCT WITH PHYSIOLOGICAL COOLING EFFECT
US4150052A (en) * 1971-02-04 1979-04-17 Wilkinson Sword Limited N-substituted paramenthane carboxamides
US4190643A (en) * 1971-02-04 1980-02-26 Wilkinson Sword Limited Compositions having a physiological cooling effect
WO1993023005A1 (en) * 1992-05-18 1993-11-25 The Procter & Gamble Company Coolant compositions
US6348625B1 (en) * 2000-11-10 2002-02-19 Gloria Long Anderson Method for preparing some 1-adamantancecarboxamides
US20050187211A1 (en) * 2004-02-23 2005-08-25 Wei Edward T. N-arylsalkyl-carboxamide compositions and methods
WO2006092076A2 (en) * 2005-03-02 2006-09-08 Givaudan Sa Carboxylic acid amides provoking a cooling sensation

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1179261A (en) * 1915-10-25 1916-04-11 Ralph Wymore Wireless check-row planter.
US3516943A (en) 1966-12-06 1970-06-23 Ncr Co Replacement of capsule contents by diffusion
US4136163A (en) * 1971-02-04 1979-01-23 Wilkinson Sword Limited P-menthane carboxamides having a physiological cooling effect
GB1351761A (en) * 1971-02-04 1974-05-01 Wilkinson Sword Ltd Substituted p-menthane carboxamides and compositions containing them
US4285984A (en) 1976-08-09 1981-08-25 Givaudan Corporation Flavoring with dialkylamino-alkylene mercaptans and sulfides
US4797411A (en) * 1986-07-18 1989-01-10 Farmitalia Carlo Erba S.P.A. Cycloalkyl-substituted 4-pyridyl derivatives and use as aromatase inhibitors
US5009893A (en) * 1989-07-17 1991-04-23 Warner-Lambert Company Breath-freshening edible compositions of methol and a carboxamide
US5759599A (en) 1992-03-30 1998-06-02 Givaudan Roure Flavors Corporation Method of flavoring and mechanically processing foods with polymer encapsulated flavor oils
EP0814751A1 (en) * 1995-03-16 1998-01-07 The Procter & Gamble Company Coolant compositions
US5843466A (en) * 1995-08-29 1998-12-01 V. Mane Fils S.A. Coolant compositions
EP0859554B1 (en) 1995-10-27 2002-05-22 Givaudan SA Aromatic granulated material
US6306818B1 (en) 1996-06-24 2001-10-23 Givaudan Roure (International) Sa Fragrance precursors
PL332644A1 (en) 1996-10-09 1999-09-27 Givaudan Roure Int Method of obtaining minute beads constituting a food or tobacco additive
PL332669A1 (en) 1996-10-09 1999-09-27 Givaudan Roure Int Method of obtaining minute beads constituting a food additive
US6039901A (en) 1997-01-31 2000-03-21 Givaudan Roure Flavors Corporation Enzymatically protein encapsulating oil particles by complex coacervation
US6106875A (en) 1997-10-08 2000-08-22 Givaudan Roure (International) Sa Method of encapsulating flavors and fragrances by controlled water transport into microcapsules
US6045835A (en) 1997-10-08 2000-04-04 Givaudan Roure (International) Sa Method of encapsulating flavors and fragrances by controlled water transport into microcapsules
SG74666A1 (en) 1997-10-21 2000-08-22 Givaudan Roure Int Beta-ketoester
SG71201A1 (en) 1998-04-20 2000-03-21 Givaudan Roure Int Hydroxa-methyl-hexanones
ATE367845T1 (en) 1998-06-15 2007-08-15 Procter & Gamble FRAGRANCE COMPOSITIONS
CA2301170A1 (en) 1998-07-17 2000-01-27 Givaudan Roure (International) Sa Dicarboalkoxy dioxolanes
EP0987018A3 (en) 1998-08-27 2000-04-26 Givaudan Roure (International) S.A. Post-foaming shower gel
US6108875A (en) * 1999-05-18 2000-08-29 National Molding Corp. Lockable strap divider
US6805893B2 (en) 1999-05-28 2004-10-19 Givaudan Sa Mercapto-alkanol flavor compounds
DE60006448T2 (en) 1999-05-28 2004-08-26 Givaudan S.A. Mercapto alcohol compounds than as flavorings
US6689740B1 (en) 1999-06-15 2004-02-10 Givaudan Sa Method for preparing fragrance products
ZA200003120B (en) 1999-06-30 2001-01-02 Givaudan Roure Int Encapsulation of active ingredients.
AU7247000A (en) 2000-01-11 2001-07-19 Givaudan Sa Composite materials
US6335047B1 (en) 2000-11-06 2002-01-01 Givaudan Sa Epoxydecenal isomers
US6451366B1 (en) 2000-11-06 2002-09-17 Givaudan Sa Epoxydecenal isomers
US20030165587A1 (en) 2002-02-28 2003-09-04 Givaudan Sa Production of 2-furfurylthiol in brassica seed and use of same
EP1348423A1 (en) 2002-03-27 2003-10-01 Givaudan SA Fragrance compositions
EP1525184A1 (en) 2002-07-25 2005-04-27 Givaudan SA Flavourant compounds
NZ538939A (en) 2002-10-21 2008-03-28 Givaudan Sa Controlled release pesticidal composition of an essential oil having pesticidal, antimicrobial and/or fungicidal properties
CN1300095C (en) 2002-10-28 2007-02-14 吉万奥丹股份有限公司 Coolant solutions and compositions comprising the sameitle
AU2003277788A1 (en) 2002-11-14 2004-06-03 Givaudan Sa Edible film containing food acid
GB0301662D0 (en) 2003-01-24 2003-02-26 Givaudan Sa Improvements in or relating to organic compounds
GB0306152D0 (en) 2003-03-19 2003-04-23 Givaudan Sa Method
JP5105873B2 (en) 2003-07-02 2012-12-26 ジェネンテック, インコーポレイテッド TRP-P8 active compounds and therapeutic treatment methods
CA2535265C (en) * 2003-08-22 2014-01-28 Dendreon Corporation Compositions and methods for the treatment of disease associated with trp-p8 expression
EP1685093B3 (en) 2003-11-21 2012-04-11 Givaudan SA N-substituted p-menthane carboxamide and use of n-substituted p-menthane carboxamides
GB0425661D0 (en) 2004-11-23 2004-12-22 Givaudan Sa Organic compounds
US20080234172A1 (en) 2004-11-29 2008-09-25 Givaudan Sa Substrate Care Product
MX2007010576A (en) * 2005-03-24 2007-10-04 Givaudan Sa Cooling compounds.

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH491111A (en) * 1966-01-28 1970-05-31 Geigy Ag J R Process for the preparation of new amides of aliphatic carboxylic acids
US4150052A (en) * 1971-02-04 1979-04-17 Wilkinson Sword Limited N-substituted paramenthane carboxamides
US4190643A (en) * 1971-02-04 1980-02-26 Wilkinson Sword Limited Compositions having a physiological cooling effect
DE2458562A1 (en) * 1973-12-12 1975-06-19 Wilkinson Sword Ltd CONSUMER PRODUCT WITH PHYSIOLOGICAL COOLING EFFECT
WO1993023005A1 (en) * 1992-05-18 1993-11-25 The Procter & Gamble Company Coolant compositions
US6348625B1 (en) * 2000-11-10 2002-02-19 Gloria Long Anderson Method for preparing some 1-adamantancecarboxamides
US20050187211A1 (en) * 2004-02-23 2005-08-25 Wei Edward T. N-arylsalkyl-carboxamide compositions and methods
WO2006092076A2 (en) * 2005-03-02 2006-09-08 Givaudan Sa Carboxylic acid amides provoking a cooling sensation

Cited By (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE44339E1 (en) 2003-11-21 2013-07-02 Givaudan S.A. N-substituted P-menthane carboxamides
WO2008107137A3 (en) * 2007-03-02 2009-03-26 Givaudan Nederland Services B Compositions comprising a physiological coolant
WO2008107137A2 (en) * 2007-03-02 2008-09-12 Givaudan Nederland Services B.V. Compositions comprising a physiological coolant
US8288441B2 (en) 2007-03-02 2012-10-16 Givaudan Nederland Services B.V. Compositions comprising a physiological coolant
US8357318B2 (en) 2007-05-08 2013-01-22 Givaudan S.A. Wax encapsulation
WO2008141469A2 (en) * 2007-05-23 2008-11-27 Givaudan Sa Butone derivatives useful as cooling agents
US7935848B2 (en) 2007-05-23 2011-05-03 Givaudan S.A. Butone derivatives useful as cooling agents
WO2008141469A3 (en) * 2007-05-23 2009-05-07 Givaudan Sa Butone derivatives useful as cooling agents
WO2008148234A1 (en) 2007-06-06 2008-12-11 Givaudan Sa Salt enhancement
WO2008151460A2 (en) 2007-06-13 2008-12-18 Givaudan Sa Cooling compounds
US7959958B2 (en) 2007-06-13 2011-06-14 Givaudan, S.A. Cooling compounds
WO2009012609A1 (en) 2007-07-23 2009-01-29 Givaudan Sa Amide addition reaction
JP2010534209A (en) * 2007-07-23 2010-11-04 ジボダン エス エー Amide addition reaction
US7880011B2 (en) 2007-07-23 2011-02-01 Givandan, S.A. Amide addition reaction
US8377422B2 (en) 2007-12-07 2013-02-19 Givaudan S.A. Carboxamide derivatives having cooling properties
US8309598B2 (en) 2007-12-19 2012-11-13 Givaudan S.A. Cooling compounds
WO2009115163A2 (en) * 2008-03-20 2009-09-24 Beiersdorf Ag Cooling cosmetic or dermatological preparations having a content of (1r,2s,5r)-2-isopropyl-5-methyl-n-(2-(pyridyne-2-yl)ethyl-cyclohexane carboxamide and/or (1r,2s,5r)-n-(4-(cyanomethyl)phenyl)-2-ispropyl-5-methylcyclohexane carboxamide for the reduction of erythema
WO2009115163A3 (en) * 2008-03-20 2009-11-19 Beiersdorf Ag Cooling cosmetic or dermatological preparations having a content of (1r,2s,5r)-2-isopropyl-5-methyl-n-(2-(pyridyne-2-yl)ethyl-cyclohexane carboxamide and/or (1r,2s,5r)-n-(4-(cyanomethyl)phenyl)-2-ispropyl-5-methylcyclohexane carboxamide for the reduction of erythema
WO2009115165A2 (en) * 2008-03-20 2009-09-24 Beiersdorf Ag Cooling preparations for contact with human skin and/or mucous membranes, containing (1r,2s,5r)-2-isopropyl-5-methyl-n-(2-(pyridin-2-yl)ethyl-cyclohexane carboxamide and/or (1r,2s,5r)-n-(4-(cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexane carboxamide
US8343465B2 (en) 2008-03-20 2013-01-01 Beiersdorf Ag Cooling cosmetic or dermatological preparations comprising (1R,2S,5R)-2-isopropyl-5-methyl-N-(2-(pyridin-2-yl)ethyl)-cyclohexane carboxamide and/or (1R,2S,5R)-N-(4-cyanomethyl-phenyl)-2-isopropyl-5-methylcyclohexane carboxamide for reducing skin reddening
US20090306152A1 (en) * 2008-03-20 2009-12-10 Beiersdorf Ag. Cooling cosmetic or dermatological preparations comprising (1r,2s,5r)-2-isopropyl-5-methyl-n-(2-(pyridin-2-yl)ethyl)-cyclohexane carboxamide and/or (1r,2s,5r)-n-(4-cyanomethyl-phenyl)-2-isopropyl-5-methylcyclohexane carboxamide in combination with menthoxypropanediol
WO2009115164A2 (en) * 2008-03-20 2009-09-24 Beiersdorf Ag Cooling cosmetic or dermatological preparations having a content of (1r,2s,5r)-2-isopropyl-5-methyl-n-(2-(pyridyne-2-yl)ethyl-cyclohexane carboxamide and/or (1r,2s,5r)-n-(4-(cyanomethyl)phenyl)-2-isopropyl-5- methylcyclohexane carboxamide comprising menthoxypropane diol
WO2009127282A1 (en) * 2008-03-20 2009-10-22 Beiersdorf Ag Preparations for reducing itching and other paraesthesias which with (1r,2s,5r)-2-isopropyl-5-methyl-n-(2-(pyridin-2yl)ethylcyclohexyl carboxamide and/or (1r,2s,5r)-n84-(cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexyl carboxamide
WO2009115164A3 (en) * 2008-03-20 2009-11-19 Beiersdorf Ag Cooling cosmetic or dermatological preparations having a content of (1r,2s,5r)-2-isopropyl-5-methyl-n-(2-(pyridyne-2-yl)ethyl-cyclohexane carboxamide and/or (1r,2s,5r)-n-(4-(cyanomethyl)phenyl)-2-isopropyl-5- methylcyclohexane carboxamide comprising menthoxypropane diol
WO2009115165A3 (en) * 2008-03-20 2009-11-19 Beiersdorf Ag Cooling preparations for contact with human skin and/or mucous membranes, containing (1r,2s,5r)-2-isopropyl-5-methyl-n-(2-(pyridin-2-yl)ethyl-cyclohexane carboxamide and/or (1r,2s,5r)-n-(4-(cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexane carboxamide
US20120039823A1 (en) * 2008-03-20 2012-02-16 Beiersdorf Ag Preparations for reducing itching and other paraesthesias with (1r,2s,5r)-2-isopropyl-5-methyl-n-(2-(pyridin-2-yl)ethylcyclohexanecarboxamide and/or (1r,2s,5r)-n-(4-(cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexanecarboxamide and/or (1r,2s,5r)-n-(4-(cyanomethyl)-phenyl)-2isopropyl-5-methylcyclohexanecarboxamide
WO2009140783A1 (en) * 2008-05-22 2009-11-26 Givaudan Sa Cooling composition
EP3115045A2 (en) 2008-08-26 2017-01-11 Basf Se Detection and use of low molecular weight modulators of the cold menthol receptor trpm8
US8710096B2 (en) 2008-08-26 2014-04-29 Basf Se Detection and use of low molecular-weight modulators of the cold-menthol receptor TRPM8
US9346823B2 (en) 2008-08-26 2016-05-24 Basf Se Detection and use of low molecular-weight modulators of the cold-menthol receptor TRPM8
EP3103447A1 (en) 2008-08-26 2016-12-14 Basf Se Detection and use of low molecular weight modulators of the cold menthol receptor trpm8
EP3698779A1 (en) 2008-08-26 2020-08-26 Basf Se Detection and use of low molecular weight modulators of the cold menthol receptor trpm8
WO2010076123A2 (en) 2008-12-30 2010-07-08 Unilever Nv A non-freezing dentifrice composition
US8664261B2 (en) 2009-05-05 2014-03-04 Givaudan S.A. Organic compounds having cooling properties
WO2010128026A3 (en) * 2009-05-05 2011-03-31 Givaudan Sa Organic compounds having cooling properties
WO2010128026A2 (en) * 2009-05-05 2010-11-11 Givaudan Sa Organic compounds
CN102497787A (en) * 2009-07-29 2012-06-13 奇华顿股份有限公司 Improvements in or relating to organic compounds
WO2011012421A1 (en) 2009-07-29 2011-02-03 Unilever Nv A dentifrice composition comprising polyethyleneglycol and a cooling agent
WO2011012671A1 (en) 2009-07-29 2011-02-03 Givaudan Sa Improvements in or relating to organic compounds
DE102010002558A1 (en) 2009-11-20 2011-06-01 Symrise Ag Use of physiological cooling agents and agents containing such agents
EP3663366A2 (en) 2009-11-20 2020-06-10 Symrise AG Use of physiological cooling ingredients and agents containing such active ingredients
WO2011061330A2 (en) 2009-11-20 2011-05-26 Symrise Ag Use of physiological cooling active ingredients, and agents containing such active ingredients
EP3434330A1 (en) 2010-06-14 2019-01-30 Symrise AG A method for enhancing the cooling effect of a cooling compound
EP2394703A1 (en) 2010-06-14 2011-12-14 Symrise AG Cooling mixture with reinforced cooling effect of 5-methyl-2-(propan-2-yl)cyclohexyl-N-ethyloxamate
WO2010149798A2 (en) 2010-06-14 2010-12-29 Symrise Ag Use of polyols for enhancing the cooling effect of a cooling substance and cooling mixtures having an enhanced cooling effect
US9029415B2 (en) 2010-06-14 2015-05-12 Symrise Ag Cooling mixtures with an enhanced cooling effect of 5-methyl-2-(propane-2-yl)cyclohexyl-N-ethyloxamate
CN103391764A (en) * 2011-02-23 2013-11-13 奇华顿股份有限公司 Organic compounds
WO2012113873A3 (en) * 2011-02-23 2013-06-06 Givaudan Sa Organic compounds
WO2012113873A2 (en) 2011-02-23 2012-08-30 Givaudan Sa Organic compounds
US10299999B2 (en) 2011-02-23 2019-05-28 Givaudan S.A. Flavour composition comprising menthol and menthane carboxamides
CN103391764B (en) * 2011-02-23 2017-04-12 奇华顿股份有限公司 organic compounds
CN104053429A (en) * 2011-07-26 2014-09-17 奇华顿股份有限公司 Rinse-off compositions
US9023776B2 (en) 2011-07-26 2015-05-05 Givaudan S.A. Rinse-off compositions comprising lactoyl ethanolamine and a menthanecarboxamide compound
WO2013014235A3 (en) * 2011-07-26 2014-08-28 Givaudan Sa Rinse-off compositions
WO2013014235A2 (en) 2011-07-26 2013-01-31 Givaudan Sa Rinse-off compositions
WO2013041621A1 (en) 2011-09-20 2013-03-28 Basf Se Low molecular weight modulators of the cold-menthol receptor trpm8 and use thereof
WO2019043164A1 (en) 2017-08-31 2019-03-07 Basf Se Use of physiological cooling active ingredients, and compositions comprising such active ingredients
US11434220B2 (en) 2017-08-31 2022-09-06 Basf Se Use of physiological cooling active ingredients, and compositions comprising such active ingredients
EP3689324A1 (en) 2019-02-04 2020-08-05 Symrise AG New cooling agents and preparations comprising them
WO2022105986A1 (en) 2020-11-17 2022-05-27 Symrise Ag Novel cooling agents and preparations containing same
WO2023143741A1 (en) 2022-01-28 2023-08-03 Symrise Ag New coolants, and preparations containing same
WO2023144326A1 (en) 2022-01-28 2023-08-03 Symrise Ag New coolants, and preparations containing same
WO2022207944A2 (en) 2022-07-11 2022-10-06 Symrise Ag Novel mixtures and uses of (2e)-3-(1,3-benzodioxol-5-yl)-n-phenyl-n-(tetrahydro-3-furanyl)-2-propenamide

Also Published As

Publication number Publication date
CN101257949A (en) 2008-09-03
US20190194134A1 (en) 2019-06-27
CN101257949B (en) 2011-01-19
US9452982B2 (en) 2016-09-27
US20170008845A1 (en) 2017-01-12
EP1917074A1 (en) 2008-05-07
US10221136B2 (en) 2019-03-05
JP2009507778A (en) 2009-02-26
ES2668361T3 (en) 2018-05-17
US20100035938A1 (en) 2010-02-11
JP5383191B2 (en) 2014-01-08
US11059783B2 (en) 2021-07-13
BRPI0616821B1 (en) 2022-06-07
EP1917074B1 (en) 2018-02-28
BRPI0616821A2 (en) 2012-04-24

Similar Documents

Publication Publication Date Title
US11059783B2 (en) Pyridinyl cyclohexanecarboxamide cooling compounds
USRE44339E1 (en) N-substituted P-menthane carboxamides
US7893110B2 (en) Carboxylic acid amides provoking a cooling sensation
EP1860960A1 (en) Cooling compounds
EP2167024B1 (en) Cooling compounds
EP1940791B1 (en) Organic compounds
US8377422B2 (en) Carboxamide derivatives having cooling properties
EP1853565B1 (en) Menthane carboxamide derivatives having cooling properties
US7935848B2 (en) Butone derivatives useful as cooling agents
US20090035364A1 (en) Para-substituted 2-alkoxyphenol compounds

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006761278

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2008526348

Country of ref document: JP

Ref document number: 771/CHENP/2008

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 200680029790.X

Country of ref document: CN

NENP Non-entry into the national phase

Ref country code: DE

WWP Wipo information: published in national office

Ref document number: 2006761278

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 11990103

Country of ref document: US

ENP Entry into the national phase

Ref document number: PI0616821

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20080215